3858 results for «2310»
3858 results
Treatment of calcified lesions
07 Oct 2022 – From AICT-AsiaPCR 2022
Consider a 66-year-old man, hypertensive and diabetic for 10 years, with history of recurrent substernal chest pain and exertional dyspnea, who presented with easy fatigability and shortness of breath, or a 72-year-old man on dialysis who presented with STEMI and severe calcified stenosis of LAD/DI bifurcation,...
Treatment of severe tricuspid regurgitation - Session with LIVE case
07 Oct 2022 – From AICT-AsiaPCR 2022
Watch the LIVE case management of an 84-year-old male patient, diabetic, hypertensive, with previous PCI on LAD and ICD, permanent AF, and exertional dyspnea for 6 months and learn more about severe tricuspid regurgitation pathology and treatment.
CTO-PCI
07 Oct 2022 – From AICT-AsiaPCR 2022
Consider a 53-year-old man with a strong family history of MI, a history of exertion angina with cycling and dyslipidemia, or a 76-year-old male patient with hypertension, type 2 diabetes, previous CABG (2017), cholecystectomy (2018), left carotid endarterectomy (2018), left leg intervention (2018), and mild aortic...
Complex PCI with left ventricular support - Session with LIVE case
07 Oct 2022 – From AICT-AsiaPCR 2022
Look at this case of a 73-year-old man, heavy smoker, with hypertension, type 2 DM, and hyperlipidemia, who recently suffered class III effort-related angina and non-ST elevation MI, who presented with a totally occluded RCA, ulcerated LM, occluded LAD, and stenotic LCx, and study LIVE a complex PCI...
Surgical turndowns interventions and outcomes
07 Oct 2022 – From AICT-AsiaPCR 2022
Through this AICT AsiaPCR 2022 session, view a variety of case presentations and hear your peers discuss them to learn how to successfully manage high-risk PCI procedures.
Rotational atherectomy for the treatment of calcified coronary lesion - Session with LIVE case
07 Oct 2022 – From AICT-AsiaPCR 2022
Let's see how this 80-year-old female patient with hypertension, hyperlipidaemia, diabetes mellitus, chronic kidney disease, history of ischaemic heart disease (2018) and NSTEMI (August 2022), currently asymptomatic but mainly homebound, was treated LIVE, and learn more about the treatment of calcified coronary lesion.
A case-based tailored approach to the treatment of mitral valve disease: the Heart Team ring
28 Nov 2022 – From PCR London Valves 2022
Join an advanced Heart Team in a real case discussion to understand what "mitral valve complexity" really means and to learn how to optimise selection between repair and replacement options.
Haemodynamic performance of transcatheter aortic valves: practical considerations for lifetime management
28 Nov 2022 – From PCR London Valves 2022
Watch this highly interactive session which focuses on the impact of haemodynamic performance on valve durability and patient survival, and how the design of bioprosthetic aortic valves influences clinical outcomes.
Tricuspid valve intervention - Get it right!
29 Nov 2022 – From PCR London Valves 2022
Watch this session if you want to learn tips and tricks that influence procedural strategy through a real-life case as well as anatomical factors that contribute to tricuspid valve complexity and choice of treatment, followed by the latest clinical data.
Maintaining selective coronary access after TAVI and re-do TAVI procedures
28 Nov 2022 – From PCR London Valves 2022
Watch this session if you want to understand the various challenges when trying to get coronary access after TAVI, learn different techniques and discuss the options for coronary access after re-do TAVI.
Innovations in TMVR and Intrepid trial updates
29 Nov 2022 – From PCR London Valves 2022
Watch this session if you want to gain insights on the APOLLO TMVR trial, the Intrepid trial and to hear about future innovations in mitral replacement.
The VitaFlow TAVI system - A new device that delivers exceptional patient outcomes
29 Nov 2022 – From PCR London Valves 2022
In this session, a panel of experts introduce the VitaFlow TAVI system, a good option for patients with complex anatomies. They also present the five-year results of VitaFlow in severe aortic stenosis.
Transfemoral TAVI access using intravascular lithotripsy in patients with challenging peripheral vascular disease
28 Nov 2022 – From PCR London Valves 2022
Watch this session to appreciate why it is better to tackle difficult transfemoral access rather than considering alternative access strategies and understand how intravascular lithotripsy mitigates procedural risk.
Contemporary best clinical practice for TAVI
28 Nov 2022 – From PCR London Valves 2022
Watch this case-based presentation to learn how to choose the right valve for the individual patient and how patient-tailored valve implantation techniques may optimise long-term outcomes.
Clinical update and best practices for optimal large bore management with the MANTA closure device
29 Nov 2022 – From PCR London Valves 2022
Watch this session if you want to get an overview of the most recent clinical evidence regarding large bore closure devices and participate in a critical discussion on the most relevant clinical data and best practices in large bore management.
TAVI: new devices and procedural refinements
27 Nov 2022 – From PCR London Valves 2022
Consult this session dedicated to TAVI new devices and procedural refinements to learn more about Meril's Myval transcatheter heart valve, the newest EVOLUT-FX self-expanding supra-annular valve, the OctaAlign technique with the novel Myval octacor transcatheter heart valve, and more!
TAVI innovations
27 Nov 2022 – From PCR London Valves 2022
Discover some of the latest innovations in TAVI presented at PCR LV 2022: zero-contrast TAVI, emerging technique for coronary protection in ViV TAVR, first dedicated splitting device in a degenerated TAVR at risk for double coronary obstruction, and much more!
Primary mitral regurgitation: key imaging requirements for diagnosis and procedural planning
27 Nov 2022 – From PCR London Valves 2022
In this session, find out more about the most common types of primary mitral regurgitation and methods for their evaluation, the principal indications for intervention, as well as the available modes of therapy (surgical/transcatheter) and most appropriate choices for individual patients.
Tricuspid interventions
27 Nov 2022 – From PCR London Valves 2022
How to manage tricuspid valve disease in a patient with atrial fibrillation, transcatheter tricuspid valve repair with transthoracic echocardiography guidance, or a patient with severe tricuspid regurgitation with a novel transcatheter treatment? Watch this PCR LV 2022 session for answers!
Rapid-fire clinical cases: session 2
27 Nov 2022 – From PCR London Valves 2022
Discover in the same PCR LV 2022 session a TAVI for pure aortic regurgitation in degenerated aortic homograft, an embolised Myval transcatheter heart valve to AAA, or a challenging ViV TAVI, and much more!
